Sunmax Biotechnology Co Ltd (4728) — Free Cash Flow Generation Index
Sunmax Biotechnology Co Ltd (4728) has a Free Cash Flow Generation Index of 0.89x as of September 2025. Free cash flow of NT$143.40 Million represents 1% of operating cash flow (NT$160.84 Million). See Sunmax Biotechnology Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sunmax Biotechnology Co Ltd Free Cash Flow Generation Index (2016–2024)
Historical FCF Generation Index trend for Sunmax Biotechnology Co Ltd across 9 annual periods. Explore Sunmax Biotechnology Co Ltd (4728) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Free Cash Flow Generation Index for Sunmax Biotechnology Co Ltd. For the full company profile including market capitalisation, see how much is Sunmax Biotechnology Co Ltd worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$360.75 Million | NT$397.37 Million | NT$36.61 Million | ▲ +4.4% |
| 2023 | 0.87x | NT$738.16 Million | NT$848.56 Million | NT$110.39 Million | ▲ +56.3% |
| 2022 | 0.56x | NT$190.94 Million | NT$342.97 Million | NT$152.03 Million | ▲ +1215.2% |
| 2021 | -0.05x | NT$-12.14 Million | NT$243.28 Million | NT$255.43 Million | ▼ -107.5% |
| 2020 | 0.66x | NT$256.88 Million | NT$386.97 Million | NT$130.10 Million | ▼ -29.0% |
| 2019 | 0.94x | NT$270.70 Million | NT$289.51 Million | NT$13.68 Million | ▼ -1.8% |
| 2018 | 0.95x | NT$96.00 Million | NT$100.83 Million | NT$4.72 Million | ▲ +5.6% |
| 2017 | 0.90x | NT$33.44 Million | NT$37.09 Million | NT$3.15 Million | ▼ -29.9% |
| 2016 | 1.29x | NT$21.31 Million | NT$16.58 Million | NT$4.73 Million | — |